"Europe Point-Of-Care-Testing (POCT) Market Summary:

According to the latest report published by Data Bridge Market Research, the Europe Point-Of-Care-Testing (POCT) Market

CAGR Value

The Europe Point-Of-Care-Testing (POCT) Market size was valued at USD 16.43 billion in 2025 and is expected to reach USD 33.65 billion by 2033, ****at a CAGR of 9.4% during the forecast period

Europe Point-Of-Care-Testing (POCT) Market report has been framed by chewing over an array of market parameters. These factors include but are not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. For market segmentation research and study carried out in the winning Europe Point-Of-Care-Testing (POCT) Market report, a market of potential customers is classified into groups or segments based on different characteristics such as application of product, deployment model, end user and geographical region etc.

Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/europe-poct-market

Europe Point-Of-Care-Testing (POCT) Market Segmentation and Market Companies

Segments:

• By Product (Glucose Monitoring Kits, Infectious Disease Testing Kits, Pregnancy and Fertility Testing Kits, Coagulation Monitoring Kits, Hematology Testing Kits, Cardiac Markers, Cholesterol Test Strips, Urinalysis Test Strips, Drug-of-abuse Test Kits, Tumor/Cancer Markers, Others)
• By Prescription Mode (Prescription-Based, Over-the-Counter)
• By Distribution Channel (Direct Tenders, Retail)
• By End-User (Hospitals, Clinics, Ambulatory Care, Home Healthcare, Research Laboratories, Others)
• By Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe)

The Europe Point-Of-Care-Testing (POCT) market is segmented based on various factors that play a crucial role in shaping the industry dynamics. The product segment includes a wide range of testing kits such as glucose monitoring kits, infectious disease testing kits, and pregnancy testing kits, catering to different healthcare needs. The prescription mode segment highlights the difference between prescription-based and over-the-counter testing kits, which can affect accessibility and usage patterns. Distribution channels like direct tenders and retail outlets also impact market reach and availability. Additionally, the diverse end-user base, including hospitals, clinics, and home healthcare settings, showcases the adaptability of POCT in different healthcare settings across Europe.

Market Players:

• F. Hoffmann-La Roche Ltd
• Abbott
• Siemens Healthcare GmbH
• BD
• bioMérieux SA